|
ANKRD28 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.36990000000081E-05 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.282860E-03 |
| Normal-vs-Stage2 |
8.440000E-04 |
| Normal-vs-Stage3 |
4.2172000000007E-05 |
| Normal-vs-Stage4 |
2.26219999999167E-06 |
| Stage1-vs-Stage2 |
3.461000E-01 |
| Stage1-vs-Stage3 |
1.874770E-01 |
| Stage1-vs-Stage4 |
1.012150E-02 |
| Stage2-vs-Stage3 |
9.900200E-01 |
| Stage2-vs-Stage4 |
3.104000E-01 |
| Stage3-vs-Stage4 |
2.424400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.11160000000277E-05 |
| Normal-vs-AfricanAmerican |
6.997800E-02 |
| Normal-vs-Asian |
1.150460E-02 |
| Caucasian-vs-AfricanAmerican |
4.251200E-01 |
| Caucasian-vs-Asian |
5.348200E-01 |
| AfricanAmerican-vs-Asian |
7.730400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.701200E-03 |
| Normal-vs-Female |
2.12119999999372E-05 |
| Male-vs-Female |
2.765600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.198200E-03 |
| Normal-vs-Age(41-60Yrs) |
3.85800000000103E-05 |
| Normal-vs-Age(61-80Yrs) |
2.4549999999568E-06 |
| Normal-vs-Age(81-100Yrs) |
2.705800E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.802400E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.075800E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.780600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.027800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.765400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.704400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.395600E-01 |
| Classical-VS-Follicular |
1.99150000002035E-06 |
| Classical-VS-Other |
6.245000E-01 |
| Classical-VS-Normal |
5.777300E-03 |
| Tall-VS-Follicular |
6.874000E-02 |
| Tall-VS-Other |
9.020400E-01 |
| Tall-VS-Normal |
3.681800E-03 |
| Follicular-VS-Other |
2.760200E-01 |
| Follicular-VS-Normal |
2.06820000014929E-08 |
| Other-VS-Normal |
1.339400E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.4563000000356E-06 |
| Normal-vs-N1 |
1.755590E-03 |
| N0-vs-N1 |
4.999000E-01 |
|
|
